UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

Radiotherapy and oncology, 1999-11, Vol.53 (2), p.113-117

1999

Volltextzugriff (PDF)

Dose Escalation Studies of Cytarabine, Daunorubicin, and Etoposide With and Without Multidrug Resistance Modulation With PSC-833 in Untreated Adults With Acute Myeloid Leukemia Younger Than 60 Years: Final Induction Results of Cancer and Leukemia Group B Study 9621

Journal of clinical oncology, 2004-11, Vol.22 (21), p.4290-4301

2004

Volltextzugriff (PDF)

Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985-1995)

Journal of the American Veterinary Medical Association, 2003-09, Vol.223 (6), p.825-831

2003

Volltextzugriff (PDF)

Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720

Blood, 2002-08, Vol.100 (4), p.1224-1232

2002

Volltextzugriff (PDF)

Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy

International journal of radiation oncology, biology, physics, 2002-05, Vol.53 (1), p.99-103

2002

Volltextzugriff (PDF)

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222

Blood, 2005-05, Vol.105 (9), p.3420-3427

2005

Volltextzugriff (PDF)

Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3767-3775

1999

Volltextzugriff (PDF)

Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia

The Lancet (British edition), 2004-02, Vol.363 (9408), p.535-536

2004

Volltextzugriff (PDF)

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine

Blood, 2001-08, Vol.98 (3), p.548-553

2001

Volltextzugriff (PDF)

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

Blood, 2001-06, Vol.97 (11), p.3574-3580

2001

Volltextzugriff (PDF)

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia

Blood, 2004-06, Vol.103 (11), p.4036-4042

2004

Volltextzugriff (PDF)

Progestin-Induced Apoptosis in the Macaque Ovarian Epithelium: Differential Regulation of Transforming Growth Factor-β

JNCI : Journal of the National Cancer Institute, 2002-01, Vol.94 (1), p.50-60

2002

Volltextzugriff (PDF)

Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression

Obstetrics and gynecology (New York. 1953), 2003-01, Vol.101 (1), p.157-163

2003

Volltextzugriff (PDF)

The Prognostic Significance of Angiogenesis in Epithelial Ovarian Carcinoma

Clinical cancer research, 1999-03, Vol.5 (3), p.587-591

1999

Volltextzugriff (PDF)

Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia

The New England journal of medicine, 1995-06, Vol.332 (25), p.1671-1677

1995

Volltextzugriff (PDF)

Additional cytogenetic abnormalities in adults with Philadelphia chromosome‐positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B

British journal of haematology, 2004-02, Vol.124 (3), p.275-288

2004

Volltextzugriff (PDF)

Epidemiologic and Surgicopathologic Findings of Papillary Serous and Clear Cell Endometrial Cancers When Compared to Endometrioid Carcinoma

Gynecologic oncology, 1999-09, Vol.74 (3), p.385-394

1999

Volltextzugriff (PDF)

A RETROSPECTIVE ANALYSIS OF 140 DOGS WITH ORAL MELANOMA TREATED WITH EXTERNAL BEAM RADIATION

Veterinary radiology & ultrasound, 2003-05, Vol.44 (3), p.352-359

2003

Volltextzugriff (PDF)

Racial Disparity in the Frequency of PTEN Mutations, but not Microsatellite Instability, in Advanced Endometrial Cancers

Clinical cancer research, 2000-08, Vol.6 (8), p.2999-3005

2000

Volltextzugriff (PDF)

Parallel Phase I Studies of Daunorubicin Given With Cytarabine and Etoposide With or Without the Multidrug Resistance Modulator PSC-833 in Previously Untreated Patients 60 Years of Age or Older With Acute Myeloid Leukemia: Results of Cancer and Leukemia Group B Study 9420

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2831-2839

1999

Volltextzugriff (PDF)

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and leukemia group B study 9311

Cancer, 2003-03, Vol.97 (6), p.1471-1480

2003

Volltextzugriff (PDF)

In Vitro and In Vivo Efficacy of the Triazole TAK-187 against Cryptococcus neoformans

Antimicrobial Agents and Chemotherapy, 1998-10, Vol.42 (10), p.2630-2632

1998

Volltextzugriff (PDF)

Sensitivity of hyperthermia trial outcomes to temperature and time: Implications for thermal goals of treatment

International journal of radiation oncology, biology, physics, 1993-01, Vol.25 (2), p.289-297

1993

Volltextzugriff (PDF)

Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420

Clinical cancer research, 2002-09, Vol.8 (9), p.2812-2819

2002

Volltextzugriff (PDF)

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(169)

Publikationsform

Sprache

Englisch
(194)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(141)
Life Sciences & Biomedicine
(131)
Humans
(118)
Biological And Medical Sciences
(100)
Medical Sciences
(96)
Female
(89)
Male
(75)
Adult
(58)
Middle Aged
(51)
Oncology
(45)
Aged
(41)
Prognosis
(41)
Adolescent
(38)
Child
(33)
Animals
(27)
Pharmacology. Drug Treatments
(27)
Hematology
(26)
Child, Preschool
(24)
Hematologic And Hematopoietic Diseases
(23)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

Dose Escalation Studies of Cytarabine, Daunorubicin, and Etoposide With and Without Multidrug Resistance Modulation With PSC-833 in Untreated Adults With Acute Myeloid Leukemia Younger Than 60 Years: Final Induction Results of Cancer and Leukemia Group B Study 9621

Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985-1995)

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720

Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy

Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222

Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered

Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia

Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia

Progestin-Induced Apoptosis in the Macaque Ovarian Epithelium: Differential Regulation of Transforming Growth Factor-β

Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression

The Prognostic Significance of Angiogenesis in Epithelial Ovarian Carcinoma

Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia

Additional cytogenetic abnormalities in adults with Philadelphia chromosome‐positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B

Epidemiologic and Surgicopathologic Findings of Papillary Serous and Clear Cell Endometrial Cancers When Compared to Endometrioid Carcinoma

A RETROSPECTIVE ANALYSIS OF 140 DOGS WITH ORAL MELANOMA TREATED WITH EXTERNAL BEAM RADIATION

Racial Disparity in the Frequency of PTEN Mutations, but not Microsatellite Instability, in Advanced Endometrial Cancers

Parallel Phase I Studies of Daunorubicin Given With Cytarabine and Etoposide With or Without the Multidrug Resistance Modulator PSC-833 in Previously Untreated Patients 60 Years of Age or Older With Acute Myeloid Leukemia: Results of Cancer and Leukemia Group B Study 9420

Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and leukemia group B study 9311

In Vitro and In Vivo Efficacy of the Triazole TAK-187 against Cryptococcus neoformans

Sensitivity of hyperthermia trial outcomes to temperature and time: Implications for thermal goals of treatment

Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420

Suchergebnisse filtern